Top compounds associated with response to AC104532.2


Feature Type Standardized
Nominal ANOVA
mRNA tacedinaline CTRPv2 pan-cancer AAC -0.0017 1
mRNA tacrolimus CTRPv2 pan-cancer AAC -0.027 0.4
mRNA tamatinib CTRPv2 pan-cancer AAC -0.052 0.2
mRNA tandutinib CTRPv2 pan-cancer AAC 0.00082 1
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.028 0.5
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.027 0.4
mRNA temsirolimus CTRPv2 pan-cancer AAC 0.079 0.1
mRNA thalidomide CTRPv2 pan-cancer AAC -0.0096 0.9
mRNA tigecycline CTRPv2 pan-cancer AAC -0.053 0.3
mRNA tipifarnib CTRPv2 pan-cancer AAC -0.025 0.4
Download CSV